Back

Jena auf Ziel: get all patients with ST-elevation myocardial infarction on EAS/ESC-LDL-C targets

29 August 2022 (16:15 - 17:00)
Organised by:
Congress Presentation Part of: Secondary prevention 3 Secondary Prevention ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Umidakhon Makhmudova

Charité - University Medicine Berlin, Berlin (Germany)

6 More presentations in this session

Presentation thumbnail
Could cholesterol remnants predict long-term cardiovascular events after NSTACS?
Doctor J. Martinon-Martinez (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
Prognostic impact of suboptimal adherence to statin therapy after STEMI: results from the FAST-STEMI registry
Doctor U. Annone (Cirie, IT)
Abstract Slides
Presentation thumbnail
Post-COVID-19 cardiovascular complications and their association with clinical characteristics, symptoms and comorbidities - the LATE-COVID study
Doctor J. Lewek (Lodz, PL)
Abstract Slides
Presentation thumbnail
The effect of trehalose administration on miRNA-10a expression in patients with history of myocardial infarction (MI) and systemic inflammation.
Professor M. Banach (Lodz, PL)
Abstract Slides
Presentation thumbnail
Risk factor recording and management in coronary heart disease patients from 32 countries: SURF CHD II
Ms A. Marza Florensa (Utrecht, NL)
Abstract Slides

Access the full session

Session thumbnail
Secondary prevention 3

The Event

Event poster

ESC Congress 2022

29 August 2022 16:15 CET
You may be interested in
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
thumbnail
Congress Presentation
Optimal medical therapy for primary prevention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources